Company Number: 13975526

Analysis Date: 2025-07-20 12:13 UTC

Financial Health Assessment for MJN & CJN LIMITED (as of 31 July 2024)

---

1. Financial Health Score: C

Explanation:
MJN & CJN LIMITED shows a mixed financial condition. While it has a positive net asset position and an increasing investment value, the company is experiencing persistent working capital deficits (negative net current assets) indicating liquidity challenges. The score "C" reflects a company with underlying financial strain that requires attention but is supported by shareholder backing and a reasonable asset base.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Cash at hand	£9,537	Low cash reserves relative to current liabilities, indicating limited immediate liquidity ("weak pulse").
Current Liabilities	£580,162	High short-term obligations; significant pressure on cash flows to meet these debts.
Net Current Assets	-£570,625	Negative working capital ("symptom of distress"), meaning liabilities exceed short-term assets by a large margin.
Total Assets less CL	£89,473	Positive but modest buffer after short-term liabilities, showing some asset backing beyond immediate debts.
Net Assets / Shareholders’ Funds	£74,440	Positive equity indicating the company has more assets than liabilities overall, a "healthy heart" sign.
Fixed Asset Investments	£660,098	Investments are the main asset, increased by £70,592 since last year, showing growth and potential value.
Provisions for liabilities	£15,033	Some anticipated future expenses or obligations, reducing net equity slightly.
Share Capital	£10,010	Stable share capital; no recent changes.
Profit & Loss Reserves	£64,430	Accumulated retained profits have grown significantly, reflecting some profitability or capital injections.

---

3. Diagnosis

MJN & CJN LIMITED's financial "vital signs" indicate a company facing liquidity challenges. The negative net current assets (working capital deficit) is a classic "symptom" of cash flow strain, meaning the company’s short-term debts significantly exceed its immediate liquid assets. The cash balance is very low, which can impair the company's ability to meet urgent financial obligations without additional funding.

However, the company’s "heart" (net assets/shareholders’ funds) remains positive and has strengthened from £20,380 last year to £74,440 currently. This improvement is driven by increased fixed asset investments and growth in profit reserves. The company is principally a holding company (SIC code 64209), so its assets are largely investments rather than operating assets like inventories or receivables.

The directors’ statement of going concern is supported by shareholder backing — notably, a large creditor balance owed to shareholders (£578,490), which likely provides financial support and flexibility. This support is crucial given the cash flow symptoms.

The restatement of prior year cash and investments suggests careful attention to accounting treatment is important, but there is no indication of misstatements affecting financial stability.

---

4. Recommendations

• Improve Liquidity Management: The company needs to address the negative working capital. Increasing cash reserves or restructuring current liabilities with shareholders or other creditors will help stabilize the "circulatory system" of the business.

• Monitor and Manage Shareholder Loans: The large creditor balance to shareholders is a double-edged sword—while it provides support, it also represents a liability that must be managed carefully to avoid future distress.

• Optimize Investment Portfolio: As investments form the bulk of assets, regular review of their valuation and realizability is key to maintaining the "organ health" of the company. Consider diversifying or liquidating non-performing investments if needed to boost liquidity.

• Maintain Strong Governance and Reporting: The company should continue transparent and timely financial reporting to detect any emerging "symptoms" early, especially as it grows.

• Plan for Contingencies: Given the liquidity risks, establish contingency plans for cash flow shortfalls, including possible capital injections or credit facilities.

---